|
Volumn 6, Issue 11, 2007, Pages 1763-1772
|
PDGFRβ and HIF-1α inhibition with imatinib and radioimmunotherapy of experimental prostate cancer
|
Author keywords
Hypoxia inducible factor 1 ; Imatinib; Insulin like growth factor 1; PC 3 xenografts; Platelet derived growth factor; Prostate cancer; Radioimmunotherapy
|
Indexed keywords
HYPOXIA INDUCIBLE FACTOR 1ALPHA;
IMATINIB;
IODINE 131;
MONOCLONAL ANTIBODY CC49 I 131;
PLATELET DERIVED GROWTH FACTOR BB;
PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;
RADIOPHARMACEUTICAL AGENT;
SOMATOMEDIN C;
VASCULOTROPIN;
ANTINEOPLASTIC AGENT;
HIF1A PROTEIN, MOUSE;
PIPERAZINE DERIVATIVE;
PLATELET DERIVED GROWTH FACTOR;
PLATELET-DERIVED GROWTH FACTOR BB;
PYRIMIDINE DERIVATIVE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIANGIOGENIC ACTIVITY;
ARTICLE;
CANCER IMMUNOTHERAPY;
CANCER INHIBITION;
CANCER RADIOTHERAPY;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
DOWN REGULATION;
DRUG DISTRIBUTION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG TUMOR LEVEL;
DRUG UPTAKE;
INHIBITION KINETICS;
MALE;
MOUSE;
MULTIPLE CYCLE TREATMENT;
NONHUMAN;
PROSTATE ADENOCARCINOMA;
PROSTATE CANCER;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
RADIOIMMUNOTHERAPY;
RADIOSENSITIVITY;
REGULATORY MECHANISM;
SINGLE DRUG DOSE;
TISSUE PRESSURE;
TREATMENT RESPONSE;
TUMOR GROWTH;
TUMOR XENOGRAFT;
ANIMAL;
DOSE RESPONSE;
DRUG ANTAGONISM;
NUDE MOUSE;
PATHOLOGY;
PROSTATE TUMOR;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT;
INSULIN-LIKE GROWTH FACTOR I;
MALE;
MICE;
MICE, NUDE;
PIPERAZINES;
PLATELET-DERIVED GROWTH FACTOR;
PROSTATIC NEOPLASMS;
PYRIMIDINES;
RADIOIMMUNOTHERAPY;
RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;
|
EID: 42549126860
PISSN: 15384047
EISSN: 15558576
Source Type: Journal
DOI: 10.4161/cbt.6.11.4854 Document Type: Article |
Times cited : (15)
|
References (75)
|